Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ALPMY | TAK | NBIX | ||
Company | Astellas Pharma Inc | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | ||
Price Information | |||||
Exchange | OTC US | NYSE | NASDAQ | ||
Open | 9.6200 | 13.09 | 140.51 | ||
High | 10.0536 | 13.20 | 142.18 | ||
Low | 9.6200 | 13.09 | 139.34 | ||
Last | 9.9900 | 13.12 | 139.40 | ||
Change | +0.1300 | +0.10 | -1.11 | ||
% Change | +1.32% | +0.77% | -0.79% | ||
Volume | 410,400 | 1,559,800 | 423,900 | ||
20-Day Average Volume | 270,330 | 1,389,670 | 716,055 | ||
Previous Close | 9.8600 | 13.02 | 140.51 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 9.7830 | 13.23 | 140.13 | ||
20-Day Raw Stochastic | 64.77% | 48.61% | 41.95% | ||
20-Day Relative Strength | 51.03% | 43.50% | 50.91% | ||
Weighted Alpha | -38.38 | -18.95 | +47.63 | ||
Today's Opinion | 88% Sell | 100% Sell | 88% Buy | ||
Previous Opinion | 88% Sell | 100% Sell | 100% Buy | ||
Last Month's Opinion | 100% Sell | 100% Sell | 96% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +5.38% since 05/17/24 | -0.76% since 05/17/24 | -2.03% since 05/17/24 | ||
Low | 9.5600 on 05/20/24 | 12.99 on 05/23/24 | 137.76 on 05/22/24 | ||
High | 10.0536 on 05/24/24 | 13.33 on 05/20/24 | 145.78 on 05/22/24 | ||
1-Month | |||||
%Chg | +5.49% since 04/24/24 | -0.83% since 04/24/24 | +0.31% since 04/24/24 | ||
Low | 9.4200 on 05/16/24 | 12.77 on 05/09/24 | 134.79 on 05/14/24 | ||
High | 10.3000 on 05/03/24 | 13.49 on 05/14/24 | 145.78 on 05/22/24 | ||
3-Month | |||||
%Chg | -9.10% since 02/23/24 | -10.26% since 02/23/24 | +3.89% since 02/23/24 | ||
Low | 9.1500 on 04/16/24 | 12.77 on 05/09/24 | 129.15 on 03/01/24 | ||
High | 11.3200 on 03/22/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | ||
6-Month | |||||
%Chg | -17.85% since 11/24/23 | -6.55% since 11/24/23 | +24.28% since 11/24/23 | ||
Low | 9.1500 on 04/16/24 | 12.77 on 05/09/24 | 110.52 on 11/27/23 | ||
High | 12.7099 on 01/08/24 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 18,078,532 | 41,522,660 | 14,028,798 | ||
Shares Outstanding, K | 1,809,663 | 3,164,837 | 100,637 | ||
Annual Sales | 11,108,100,000 | 29,419,960,000 | 1,887,100,000 | ||
Annual Net Income | 118,070,000 | 994,060,000 | 249,700,000 | ||
Last Quarter Sales | 2,793,590,000 | 5,397,000,000 | 515,300,000 | ||
Last Quarter Net Income | -224,230,000 | -91,000,000 | 43,400,000 | ||
60-Month Beta | 0.37 | 0.56 | 0.28 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.11 on 04/25/24 | 0.00 on 05/09/24 | 0.42 on 05/01/24 | ||
Latest Earnings Date | 04/25/24 | 05/09/24 | 05/01/24 | ||
Most Recent Dividend | 0.168 on 09/27/23 | 0.261 on 09/28/23 | N/A | ||
Next Ex-Dividends Date | 09/27/23 | 09/28/23 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 28.17 | 8.35 | 38.71 |